AAAAAA

   
Results: 1-21 |
Results: 21
Comparison of cytology and nuclear matrix protein 22 for the detection andfollow-up of bladder cancer
Authors: Lahme, S Bichler, KH Feil, G Krause, S
Citation: S. Lahme et al., Comparison of cytology and nuclear matrix protein 22 for the detection andfollow-up of bladder cancer, UROL INTERN, 66(2), 2001, pp. 72-77
The inactive form of pyruvate kinase in tumour diagnosis: An overview of the current state of research
Authors: Wechsel, HW Feil, G Oremek, GM Bichler, KH Gleichmann, R
Citation: Hw. Wechsel et al., The inactive form of pyruvate kinase in tumour diagnosis: An overview of the current state of research, AKT UROL, 32(2), 2001, pp. 55-61
Investigations on cytokines in serum of patients with Peyronie's disease
Authors: Feil, G Bichler, KH Lahme, S Gotz, T
Citation: G. Feil et al., Investigations on cytokines in serum of patients with Peyronie's disease, AKT UROL, 32, 2001, pp. 33-36
Investigations on collagen metabolism in patients with induratio penis plastica
Authors: Lahme, S Feil, G Bichler, KH
Citation: S. Lahme et al., Investigations on collagen metabolism in patients with induratio penis plastica, AKT UROL, 32, 2001, pp. 37-40
Induratio penis plastica and genetic variation of the alpha-1-antitrypsin locus
Authors: Kompf, J Tomiuk, J Feil, G Lahme, S Bichler, KH
Citation: J. Kompf et al., Induratio penis plastica and genetic variation of the alpha-1-antitrypsin locus, AKT UROL, 32, 2001, pp. 41-43
Molecular genetic methods in the diagnosis of invasive bladder cancer
Authors: Krause, FS Feil, G Zumbragel, A Bichler, KH
Citation: Fs. Krause et al., Molecular genetic methods in the diagnosis of invasive bladder cancer, ANTICANC R, 20(6D), 2000, pp. 5015-5021
Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer
Authors: Krause, FS Feil, G Bichler, KH
Citation: Fs. Krause et al., Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer, ANTICANC R, 20(6D), 2000, pp. 5023-5028
Serologic angiogenesis factors and microvascular density in renal cell carcinoma: Two independent parameters
Authors: Wechsel, HW Feil, G Bichler, KH Beiter, T Gleichmann, R
Citation: Hw. Wechsel et al., Serologic angiogenesis factors and microvascular density in renal cell carcinoma: Two independent parameters, ANTICANC R, 20(6D), 2000, pp. 5117-5120
Renal cell carcinoma. Immunohistological study to the expression of the inactive form of the pyruvatekinase
Authors: Wechsel, HW Petri, E Feil, G Nelde, HJ Bichler, KH
Citation: Hw. Wechsel et al., Renal cell carcinoma. Immunohistological study to the expression of the inactive form of the pyruvatekinase, UROLOGE, 38(6), 1999, pp. 583-585
Urosepsis. Clinical picture, immunopathogenesis and therapy
Authors: Zumbragel, A Feil, G Bichler, KH
Citation: A. Zumbragel et al., Urosepsis. Clinical picture, immunopathogenesis and therapy, NIEREN HOCH, 28(4), 1999, pp. 115
Renal abscess - diagnosis and therapy
Authors: Bichler, KH Zumbragel, A Feil, G Michels, A
Citation: Kh. Bichler et al., Renal abscess - diagnosis and therapy, NIEREN HOCH, 28(4), 1999, pp. 146-151
Bilharziasis (schistosomiasis) of the bladder - pathogenesis, diagnostics,therapy and uroprotection
Authors: Bichler, KH Neide, HJ Feil, G Krause, FS Zumbragel, A
Citation: Kh. Bichler et al., Bilharziasis (schistosomiasis) of the bladder - pathogenesis, diagnostics,therapy and uroprotection, NIEREN HOCH, 28(3), 1999, pp. 102-108
Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
Authors: Wechsel, HW Feil, G Lahme, S Zumbragel, A Petri, E Bichler, KH
Citation: Hw. Wechsel et al., Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?, ANTICANC R, 19(4A), 1999, pp. 2577-2581
Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinasetype M-2 (Tu M2-PK)
Authors: Wechsel, HW Petri, E Bichler, KH Feil, G
Citation: Hw. Wechsel et al., Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinasetype M-2 (Tu M2-PK), ANTICANC R, 19(4A), 1999, pp. 2583-2590
Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas
Authors: Feil, G Wechsel, HW Nelde, HJ Bichler, KH
Citation: G. Feil et al., Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas, ANTICANC R, 19(4A), 1999, pp. 2591-2597
Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma
Authors: Feil, G Leipoldt, M Nelde, HJ Wunderer, A Wechsel, HW Kaiser, P Bichler, KH
Citation: G. Feil et al., Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma, ANTICANC R, 19(2C), 1999, pp. 1477-1482
DNA cytophotometry in renal cell carcinoma: A significant prognostic factor?
Authors: Feil, G Mittermuller, S Bichler, KH Wunderer, A Wechsel, HW Nelde, HJ Krause, FS
Citation: G. Feil et al., DNA cytophotometry in renal cell carcinoma: A significant prognostic factor?, ANTICANC R, 19(2C), 1999, pp. 1483-1486
Renal cell carcinoma: Immunohistological investigation of expression of the integrin alpha v beta 3
Authors: Wechsel, HW Petri, E Feil, G Nelde, HJ Bichler, KH Loesr, W
Citation: Hw. Wechsel et al., Renal cell carcinoma: Immunohistological investigation of expression of the integrin alpha v beta 3, ANTICANC R, 19(2C), 1999, pp. 1529-1532
Renal cell carcinoma: Relevance of angiogenetic factors
Authors: Wechsel, HW Bichler, KH Feil, G Loeser, W Lahme, S Petri, E
Citation: Hw. Wechsel et al., Renal cell carcinoma: Relevance of angiogenetic factors, ANTICANC R, 19(2C), 1999, pp. 1537-1540
Excretion of Tamm-Horsfall protein in patients with uric acid stones
Authors: Bichler, KH Mittermuller, B Strohmaier, WL Feil, G Eipper, E
Citation: Kh. Bichler et al., Excretion of Tamm-Horsfall protein in patients with uric acid stones, UROL INTERN, 62(2), 1999, pp. 87-92
Plasma-inactive form of pyruvate kinase (pTuM2Pk) in renal cell carcinoma (RCC): An acceptable marker?
Authors: Wechsel, HW Feil, G Lahme, S Loeser, W Bichler, KH
Citation: Hw. Wechsel et al., Plasma-inactive form of pyruvate kinase (pTuM2Pk) in renal cell carcinoma (RCC): An acceptable marker?, AKT UROL, 30(4), 1999, pp. 249-253
Risultati: 1-21 |